Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© Shutterstock

The Review on Antimicrobial Resistance, which attracted national media attention around the publication of its final report on 19th May, includes a supporting document from diagnostics researchers Dr Ann Van den Bruel and Dr Philip Turner from the NIHR Diagnostics Evidence Cooperative Oxford.

Forecast Diagnostics for Antimicrobial Resistance explores the outlook for diagnostic technologies in primary care over the next 15–20 years, which could be used to support the diagnosis of microbial infection in patients by healthcare professionals.

The forecast report is one of seven independently produced documents that have been considered by the AMR Review chair Lord O'Neill of Gatley and its advisory group in developing their recommendations for tackling drug-resistant infections globally. Professor Carl Heneghan, Director of the Centre for Evidence Based Medicine, is also acknowledged for his contribution to the Review.

The AMR Review, commissioned by UK Government in 2014, has engaged widely with international stakeholders to understand and propose solutions to the problem of antimicrobial resistance, from an economic and social perspective.

Find out more about the NIHR DEC Oxford, hosted in the Nuffield Department of Primary Care Health Sciences.


Contact our communications team

Opinions expressed are those of the authors and not of Oxford University. Readers' comments will be moderated - see our guidelines for further information.